Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

समान संसाधन

• Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer
  द्वारा: Androulakis, N, और अन्य
  प्रकाशित: (2012)
• Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
  द्वारा: Saloustros, Emmanouil, और अन्य
  प्रकाशित: (2011)
• Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
  द्वारा: Daskalaki, A, और अन्य
  प्रकाशित: (2009)
• Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes
  द्वारा: Kalbakis, K, और अन्य
  प्रकाशित: (2001)
• Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer
  द्वारा: Agelaki, Sofia, और अन्य
  प्रकाशित: (2015)